XTX Topco’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

XTX Topco’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,150	Closed	-$89K	–	1167
2021 Q2	$89K	Buy	+14,150	New	+$91.3K	0.03%	675

Other funds holding ISEE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's ISEE Position: Q3 2021 in Review

XTX Topco sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2021, closing a stake of 14,150 shares — an estimated $89K sold.

XTX Topco first reported a position in ISEE in Q2 2021 and held it in 1 quarter. The position peaked at $89K in Q2 2021. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.

XTX Topco reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
XTX Topco sold 14,150 IVERIC bio, Inc. Common Stock shares in Q3 2021, an estimated $89K.
XTX Topco first reported a position in IVERIC bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
XTX Topco's IVERIC bio, Inc. Common Stock position peaked at $89K in Q2 2021.
149 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2021.

Based on XTX Topco's 13F filing for Q3 2021, filed 12 Nov 2021.